Core Wealth Partners’s AbbVie ABBV Stock Holding History

Core Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.75M	Sell	6,948 -709	-9%	-$153K	0.74%	35
2026 Q1	$1.67M	Sell	7,657 -87	-1%	-$19.3K	0.77%	37
2025 Q4	$1.77M	Buy	7,744 +94	+1%	+$21.4K	0.8%	38
2025 Q3	$1.77M	Buy	7,650 +90	+1%	+$18.3K	0.81%	41
2025 Q2	$1.4M	Buy	7,560 +4,218	+126%	+$784K	0.71%	40
2025 Q1	$700K	Sell	3,342 -828	-20%	-$161K	0.41%	61
2024 Q4	$741K	Buy	4,170 +286	+7%	+$52.6K	0.42%	56
2024 Q3	$767K	Buy	3,884 +845	+28%	+$158K	0.47%	56
2024 Q2	$521K	Buy	3,039 +58	+2%	+$9.61K	0.36%	65
2024 Q1	$543K	Buy	2,981 +48	+2%	+$8.27K	0.41%	53
2023 Q4	$454K	Sell	2,933 -85	-3%	-$12.4K	0.37%	57
2023 Q3	$450K	Sell	3,018 -30	-1%	-$4.4K	0.41%	55
2023 Q2	$411K	Sell	3,048 -70	-2%	-$10.3K	0.38%	59
2023 Q1	$497K	Sell	3,118 -2,076	-40%	-$317K	0.5%	50
2022 Q4	$612K	Buy	+5,194	New	+$796K	0.69%	41

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Core Wealth Partners's ABBV Position: Q2 2026 in Review

Core Wealth Partners reduced its AbbVie (ABBV) stake by 9.3% in Q2 2026, selling an estimated $153K and leaving 6,948 shares worth $1.75M. The position accounts for 0.74% of the portfolio, ranked #35.

Core Wealth Partners first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.77M in Q3 2025. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Core Wealth Partners held 6,948 shares of AbbVie worth $1.75M as of Q2 2026.
Core Wealth Partners sold 709 AbbVie shares in Q2 2026, an estimated $153K.
AbbVie made up 0.74% of Core Wealth Partners's portfolio in Q2 2026, its #35 holding.
Core Wealth Partners first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
Core Wealth Partners's AbbVie position peaked at $1.77M in Q3 2025.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Core Wealth Partners's 13F filing for Q2 2026, filed 17 Jul 2026.